: Developing new antibiotics is expensive, leading pharmaceutical companies to prioritize more profitable drugs for chronic conditions instead.
The overuse and misuse of antibiotics are primary contributors to the development of antibiotic resistance. The widespread prescription of antibiotics for viral infections, such as the common cold, and the use of broad-spectrum antibiotics, have accelerated the emergence of resistant bacteria. Additionally, the lack of new antibiotics being developed and the inadequate infection control practices in healthcare settings have exacerbated the problem. : Developing new antibiotics is expensive
The rise of "superbugs" is primarily driven by human behavior and economic factors: Antimicrobial resistance - World Health Organization (WHO) such as the common cold